MS
Gut Microbiome in Multiple Sclerosis Varies by Disease Course, Treatment Approach
Researchers from the International Multiple Sclerosis Microbiome Study compared the gut microbiomes of MS patients and healthy household controls.
The company has slightly extended its timeline for launching a Lyme disease test to focus on marketing its COVID assay for immunocompromised individuals.
In research presented at the AMIA Informatics Summit, University of Texas bioinformaticians tried a new algorithm to include epigenetic factors in predicting disease progression.
T Cell Gene Expression In Multiple Sclerosis CSF Reflects Elevated Activation, Cytotoxicity
Researchers profiled T cells in the cerebrospinal fluid of healthy individuals and multiple sclerosis patients using single-cell RNA-seq and T cell receptor sequencing.
Based in Boston with operations in Ireland and Iceland, the reorganized company is supporting COVID-19 testing and population genomics as it sheds its China division.